The Feasibility of Drug Delivery to Infants During Breastfeeding

NACompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

July 9, 2018

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Medication SystemsBreast FeedingMilk, HumanInfant, Newborn
Interventions
DEVICE

Drug delivery during breastfeeding

This study aims to give a vitamin B12 supplement to babies during breastfeeding. 30 mother-infant pairs will be recruited. The supplement will be placed into a nipple shield, both of which are commercially available, and the mother will breastfeed her baby as usual. Before and after the feed, we will 1) collect a small blood sample from the baby to see whether the vitamin levels in the infant have increased, 2) ask the mother to participate in two short interviews about her expectations and experiences using the Therapeutic Nipple Shield.

Trial Locations (1)

Unknown

addenbrookes Hospital, Cambridge

All Listed Sponsors
collaborator

University of Cambridge

OTHER

lead

Cambridge University Hospitals NHS Foundation Trust

OTHER

NCT03799367 - The Feasibility of Drug Delivery to Infants During Breastfeeding | Biotech Hunter | Biotech Hunter